Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial. uri icon

authors

  • Hakeem, Abdul
  • Manish Kumar, MD
  • Manish Kumar, MD
  • Awan, Romana
  • Ishaq, Haroon
  • Farooq, Faiza
  • Haq, Ejaz Ul
  • Hameed, Abdul
  • Lehri, Waheed A
  • Zada, Shakir
  • Ali, Asif
  • Shah, Jehangir Ali
  • Raza, Ahsan
  • Masood, Sobia
  • Humza, Ahmadullah
  • Karim, Musa
  • Kumar, Rajesh
  • Ali, Asim
  • Lakho, Ahsan Ali
  • Zeeshan, Hamayal
  • Uddin, Muhammad Inam
  • Khan, Kamran
  • Solangi, Bashir

publication date

  • August 30, 2025